Plethico Pharmaceuticals Ltd |
---|
Registered Office: A B Road,Manglia,Indore-453771, Madhya Pradesh |
Tel. No: 91-731-2806271/2806275 |
Fax No: 91-731-2806271 |
Email: pledge@plethico.com |
Website: www.plethico.com |
Public issue of 3,666,667 equity shares of Rs. 10 each for cash at a price of Rs. 300 per equity share (including a share premium of Rs. 290 per equity share) aggregating Rs. 110.00 crores, (The "Issue"), by Plethico Pharmaceuticals Limited ("Plethico", the "Company" or "The Issuer"). The Issue constitutes 10.76% of the fully diluted post-issue paid up capital of the company. Issue price Rs.300 per equity share of face value Rs. 10 Issue price is 30 times of the face value. |
Issue | Money Payable On | ||
---|---|---|---|
Opens On | Closes On | Application | Allotment |
10-Apr-2006 | 17-Apr-2006 | ₹300.00 - 0.00 | ₹0.00 - 0.00 |
Minimum Application for shares in Nos : 20 | Further Multiples of :20 |
---|
(₹ Cr) | Lead Managers to the Issue | |
---|---|---|
Project Cost | 144.67 | Anand Rathi Securities Pvt Ltd |
Project Financed through Current Offer | 110.00 | |
Post Issue Equity Share Capital | 34.07 | |
Issue Price | 300.00 |
Projects |
---|
Upgradation - Kalaria plant for UK MHRA compliance |
Setting up of a plant in Jammu & Kashmir(J&K) |
Setting-up of R&D and Formulations & Devel. centre |
Acquiring a stake in a OTC/domestic herbal/a Brand |
Setting up a corporate office in Mumbai |
To meet the working capital req. of business |
Promoted By |
---|
Shashikant Patel |
Chirag Patel |
Gauravi Parikh |
Listing At |
---|
BSE |
NSE |
Registrar To The Issue |
---|